• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Be bold bonus


<



















Such bullshit that they didn't give out raises. Instead let's give unattainable growth goals that less than 8% of sales force can attain
So Allergan saves money by not giving raises and ultimately saves money each year
 




Similar threads

Replies
9
Views
3K
Replies
2
Views
2K
Replies
6
Views
3K
Allergan
anonymous